Immunoglobulin transgenes as targets for somatic hypermutation. 1998

U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
Department of Molecular Genetics and Cell Biology, University of Chicago, IL 60637, USA. stor@midway.uchicago.edu

This review describes studies on somatic hypermutation of immunoglobulin genes that were started in the mid-80s in collaboration with Ralph Brinster. Almost all of the experiments were carried out using Ig transgenes as targets for the somatic mutation mechanism. Ig transgenes can be very good targets of somatic mutation, despite many different transgene integration sites. Thus, the required cis-acting elements must be present within the approximately 10 kb of the transgene. Only the Ig variable region and its proximate flanks are mutated, not the constant region in unmanipulated sequences. Several Ig gene enhancers are permissive for somatic mutation and they do not have to be associated with the Ig promoter they normally interact with. However, the mutation process does seem to be specific for Ig genes. No mutations were found in several housekeeping genes isolated from cells that had very high levels of somatic hypermutation of their Ig genes. This suggests that the Ig enhancers provide the lg gene specificity. An exception is the Bcl-6 gene, encoding a transcription factor, which was found to be mutated in normal human memory B cells. When the transcriptional promoter that is located upstream of the variable region is duplicated upstream of the constant region, this region is mutated as well. This suggests a transcription coupled model in which a mutator factor associates with the RNA polymerase at the initiation of transcription, travels with the polymerase during elongation, and causes mutations during polymerase pausing. Our recent data with an artificial substrate for somatic mutation suggest that the mutations are increased by increased stability of the secondary structures in the nascent RNA, and the specific nucleotides that are mutated are due to preferences of a mutator factor.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016296 Mutagenesis Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS. Mutageneses
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D019076 Transgenes Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES. Recombinant Transgenes,Recombinant Transgene,Transgene,Transgene, Recombinant,Transgenes, Recombinant

Related Publications

U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
February 2001, Immunology and cell biology,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
May 2020, Viral immunology,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
January 2007, Annual review of genetics,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
April 2002, Current opinion in immunology,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
November 1993, Proceedings of the National Academy of Sciences of the United States of America,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
February 2011, Immunology,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
January 1996, Annual review of immunology,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
May 1996, European journal of immunology,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
January 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
U Storb, and A Peters, and E Klotz, and N Kim, and H M Shen, and J Hackett, and B Rogerson, and R O'Brien, and T E Martin
September 2003, Genes, chromosomes & cancer,
Copied contents to your clipboard!